Steve T. Min is EVP & General Counsel at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX). They have made 6 open-market trades across 1 company since 2008, most recently 2010-09-28.
CIK 0001439079
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $200K since 2008, never a sale. Across 6 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VRX | 60,237 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2010-07-01 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -12.8% | +0.4% | +0.4% |
| Alpha | -7.0% | +0.2% | +0.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | BUY | 2008-08-11 | 2008-08-11 | $19.55 | $33K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-08-04 | 2008-08-04 | $17.22 | $33K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-07-28 | 2008-07-28 | $17.64 | $33K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-07-21 | 2008-07-21 | $17.29 | $33K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-07-14 | 2008-07-15 | $16.99 | $33K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-07-07 | 2008-07-08 | $16.23 | $33K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.